Drug
Caspofungin clinical trials
Also written Cancidas, MK0991 and L-743,872.
- studies test it
- 46
- open now
- 2
- in phase 3
- 11
- first study started
- 2000
Keep track of what changes. Save the Caspofungin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2004 (7)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 7 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 22
- Phase 3
- 11
- Phase 4
- 9
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 29
Merck Sharp & Dohme LLC (14) · Children's Oncology Group (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · National Cancer Institute (NCI) (2) · Assistance Publique - Hôpitaux de Paris (1) · Gary E. Stein, Pharm.D. (1) · Cttq (1) · Centre Hospitalier Universitaire de Saint Etienne (1)
Often tested with
Tested in the same studies.
Amphotericin B (3) · Liposomal amphotericin B (2) · Micafungin (1) · Fluconazole (1) · Voriconazole (1) · Adrenal Cortex Hormones (1) · Olorofim (1)
Studies
Open first, then newest update. How each study uses Caspofungin is read from its arms, and is right about nine times in ten.
Testing it · 46
- CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis PneumoniaRecruitingPhase 1/2University Hospital, ToursNCT06892951Written as Caspofungin Acetate 50 MG
- Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN TrialNot yet recruitingPhase 4Oliver Cornely, MDNCT07788586Written as Caspofungin only within the study
- Pharmacokinetics of Caspofungin in Burn PatientsCompletedPhase 2/3Assistance Publique - Hôpitaux de ParisNCT00748345Written as Caspofungin (drug)
- Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune SystemsTerminatedPhase 2OHSU Knight Cancer InstituteNCT00238355Written as caspofungin acetate
- Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantCompletedPhase 3Children's Oncology GroupNCT01503515Written as Caspofungin Acetate
- Comparison of Candida Eradication and Serum Cidal Activity of EchinocandinsCompletedPhase 4Gary E. Stein, Pharm.D.NCT00839540Written as Caspofungin
- Empirical Versus Preemptive Antifungal TherapyCompletedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT01288378Written as caspofungin acetate
- Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using CaspofunginCompletedPhase 2CttqNCT03857399Written as Caspofungin
- Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid LeukemiaCompletedPhase 3Children's Oncology GroupNCT01307579Written as Caspofungin Acetate
- Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV PatientsStatus unknownNot applicableBeijing Chao Yang HospitalNCT02603575Written as caspofungin
- Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01945281Written as Caspofungin
- Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCPStatus unknownPhase 4Bin DuNCT03978559Written as caspofungin
- Evaluation of the Pharmacokinetics of Caspofungin in ICU PatientsCompletedNot applicableCentre Hospitalier Universitaire de Saint EtienneNCT02596984Written as Caspofungin
- Pharmacokinetics of Caspofungin After One Dose in Patients With Liver FailureCompletedPhase 4Erasme University HospitalNCT01968395Written as Caspofungin 70 mg
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)CompletedPhase 2Merck Sharp & Dohme LLCNCT01165320Written as Caspofungin
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsWithdrawnPhase 1/2F2G Biotech GmbHNCT02856178Written as Caspofungin
- A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)CompletedPhase 3Merck Sharp & Dohme LLCNCT00635648Written as caspofungin acetate
- A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00250432Written as caspofungin acetate
- Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01045798Written as Caspofungin acetate
- A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00717860Written as caspofungin acetate
See all 46 studies that test Caspofungin →
As the comparator · 10 — what is tested is compared with Caspofungin
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.RecruitingPhase 3Basilea PharmaceuticaNCT05421858Written as Caspofungin
- To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver TransplantationNot yet recruitingPhase 4Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT04728971Written as Caspofungin Acetate
- A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisCompletedPhase 2Fujian Shengdi Pharmaceutical Co., Ltd.NCT06194201Written as Caspofungin Acetate for Injection
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedPhase 3Astellas Pharma IncNCT00413218Written as Caspofungin
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedPhase 3Astellas Pharma IncNCT01058174Written as caspofungin
- Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedPhase 3Cidara Therapeutics Inc.NCT03667690Written as Caspofungin
- CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedPhase 2Cidara Therapeutics Inc.NCT02734862Written as Caspofungin
- A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTerminatedPhase 4Xian-Janssen Pharmaceutical Ltd.NCT02895529Written as Caspofungin
- Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedPhase 3Astellas Pharma IncNCT00105144Written as Caspofungin
- Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedPhase 3Astellas Pharma IncNCT00665639Written as caspofungin
Codes
What other systems call Caspofungin · ClinicalTrials.gg INT006703
- MeSH (NLM) D000077336CaspofunginConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) F0XDI6ZL63CASPOFUNGINConfirmed FDA, NLM, Wikidata
- RxNorm 140108One source FDA
- Wikidata Q63413125(10R,12S)-caspofunginConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28910CaspofunginOne source FDA
- DrugBank DB00520One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077336 | Caspofungin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | F0XDI6ZL63 | CASPOFUNGIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 140108 | — | One source FDA |
| Wikidata | Q63413125 | (10R,12S)-caspofungin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28910 | Caspofungin | One source FDA |
| DrugBank | DB00520 | — | One source Wikidata |
Also registered as caspofungin acetate (UNII VUW370O5QE · RxNorm 282363).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.